Treatments & Services — Revive by MWS

Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) are prepared from a patient's own blood and contain concentrated platelets and other biological components.

These therapies may be considered as part of an individualized treatment plan for certain musculoskeletal injuries and painful conditions. Appropriate use depends on the patient's diagnosis and clinical evaluation.

Alpha-2-Macroglobulin (A2M) is a naturally occurring protein found in blood. A2M-based preparations have been explored for certain joint and musculoskeletal applications.

Cell-based therapies involve biological materials containing or derived from cells. Various cell-based approaches are being investigated for potential medical applications.

Medical ozone has been investigated for a variety of potential applications, including certain musculoskeletal uses.

Shockwave therapy uses acoustic pressure waves applied externally to targeted tissues. Depending on the patient's diagnosis, it may be considered for certain tendon and musculoskeletal conditions.

Laser therapy uses therapeutic light energy as a non-invasive treatment modality. Depending on the specific device and indication, it may be incorporated into an individualized treatment plan for certain musculoskeletal symptoms and soft-tissue conditions.

EMVITAL uses electromagnetic stimulation to activate targeted muscles. It may be incorporated into selected muscle and musculoskeletal programs based on the patient's evaluation and treatment goals.

For selected patients, EMVITAL may be incorporated into a broader treatment program involving targeted muscle stimulation.

EMSCULPT is a non-invasive technology that uses electromagnetic energy to stimulate muscle contractions. Depending on the specific device and treatment protocol, it may be used for muscle-related and body-contouring applications consistent with applicable device indications. Treatment suitability and expected outcomes are discussed during consultation.

EMSELLA is a non-invasive technology that uses electromagnetic stimulation to activate pelvic-floor muscles while the patient remains clothed and seated. It may be considered for appropriate pelvic-floor and urinary concerns when consistent with applicable device indications. A clinical evaluation helps determine whether treatment is appropriate for an individual patient.

We provide confidential, individualized evaluation for women experiencing sexual health, pelvic wellness, menopausal, and hormone-related concerns. Sexual health symptoms can have multiple causes. Treatment recommendations are therefore based on medical history, symptoms, examination, appropriate testing, and individual risk factors.

Evaluation and treatment options may be available for vaginal dryness, irritation, or discomfort associated with menopause, hormonal changes, medications, or other medical factors.

Pain during sexual activity may have hormonal, pelvic-floor, musculoskeletal, gynecologic, or other causes. Evaluation focuses on identifying potential contributing factors before recommending treatment.

Changes in sexual desire can be associated with hormonal changes, medications, medical conditions, psychological factors, stress, and other influences. An individualized evaluation may help identify potential contributors and appropriate management options.

Evaluation and management may be available for appropriate symptoms associated with perimenopause and menopause, including certain sexual, vaginal, and general wellness concerns.

Pelvic-floor dysfunction may contribute to urinary symptoms, pelvic discomfort, and some sexual health concerns. Treatment recommendations depend on the underlying condition and individual evaluation.

Peptides are short chains of amino acids involved in many biological processes. Certain peptide-based medications have FDA-approved medical uses, while other peptides remain investigational. When peptide-based treatment is considered, the specific medication, intended use, patient's medical needs, available evidence, potential risks, and regulatory status should be evaluated.

Some peptides promoted for recovery, body composition, performance, wellness, anti-aging, or other purposes are investigational and are not FDA-approved for those uses. The available evidence, safety information, legal status, and regulatory status vary significantly among individual peptide products.

When a compounded medication is prescribed, patients should understand that compounded drugs are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, and quality before marketing in the same manner as FDA-approved medications. Compounded medications may be prescribed when clinically appropriate and when permitted under applicable federal and state requirements.

Intravenous therapy delivers vitamins, minerals, and nutrients directly into the bloodstream. IV formulations are tailored to individual wellness goals and clinical needs. A clinical evaluation is performed prior to treatment.